Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

  1. Garcia-Carbonero, R.
  2. Salazar, R.
  3. Duran, I.
  4. Osman-Garcia, I.
  5. Paz-Ares, L.
  6. Bozada, J.M.
  7. Boni, V.
  8. Blanc, C.
  9. Seymour, L.
  10. Beadle, J.
  11. Alvis, S.
  12. Champion, B.
  13. Calvo, E.
  14. Fisher, K.
Zeitschrift:
Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426

Datum der Publikation: 2017

Ausgabe: 5

Nummer: 1

Art: Artikel

DOI: 10.1186/S40425-017-0277-7 GOOGLE SCHOLAR lock_openOpen Access editor